Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Sexual and reproductive health and human rights of women living with HIV.

Narasimhan M, Loutfy M, Khosla R, Bras M.

J Int AIDS Soc. 2015 Dec 1;18(6Suppl 5):20834. doi: 10.7448/IAS.18.6.20834. eCollection 2015. No abstract available.

2.

Use of VIA, Pap smear, or HR-HPV testing in women living with HIV/AIDS for post-treatment cervical cancer screening: same tests, different priorities.

Orang'o O, Liu T, Christoffersen-Deb A, Itsura P, Oguda J, Washington S, Chumba D, Pisharodi L, Cu-Uvin S, Rositch AF.

AIDS. 2016 Nov 7. [Epub ahead of print]

PMID:
27831951
3.

Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study.

Wu TJ, Smith-McCune K, Reuschenbach M, von Knebel Doeberitz M, Maloba M, Huchko MJ.

BMJ Open. 2016 Sep 13;6(9):e012547. doi: 10.1136/bmjopen-2016-012547.

4.

Immunization of HIV-infected adult patients - French recommendations.

Fr├ęsard A, Gagneux-Brunon A, Lucht F, Botelho-Nevers E, Launay O.

Hum Vaccin Immunother. 2016 Nov;12(11):2729-2741. Epub 2016 Jul 13.

5.

Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.

Bekolo CE, O'Bryan G, Tchago FE, Nangue C, Bekoule PS, Kollo B.

PLoS One. 2016 Feb 11;11(2):e0149152. doi: 10.1371/journal.pone.0149152. eCollection 2016.

6.

Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.

Li X, Stander MP, Van Kriekinge G, Demarteau N.

BMC Infect Dis. 2015 Dec 11;15:566. doi: 10.1186/s12879-015-1295-z.

7.

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries.

Huchko MJ, Maloba M, Nakalembe M, Cohen CR.

J Int AIDS Soc. 2015 Dec 1;18(Suppl 5):20282. doi: 10.7448/IAS.18.6.20282. eCollection 2015.

8.

Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.

Kapambwe S, Sahasrabuddhe VV, Blevins M, Mwanahamuntu MH, Mudenda V, Shepherd BE, Chibwesha CJ, Pfaendler KS, Hicks ML, Vermund SH, Stringer JS, Parham GP.

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):e20-6. doi: 10.1097/QAI.0000000000000685.

9.

A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008.

Mutyaba I, Phipps W, Krantz EM, Goldman JD, Nambooze S, Orem J, Wabinga HR, Casper C.

J Acquir Immune Defic Syndr. 2015 Aug 1;69(4):481-6. doi: 10.1097/QAI.0000000000000620.

10.

Outcomes Up to 12 Months After Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women.

Huchko MJ, Leslie H, Maloba M, Zakaras J, Bukusi E, Cohen CR.

J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):200-5. doi: 10.1097/QAI.0000000000000565.

11.

The diversity of human papillomavirus infection among human immunodeficiency virus-infected women in Yunnan, China.

Zhang HY, Fei MD, Jiang Y, Fei QY, Qian H, Xu L, Jin YN, Jiang CQ, Li HX, Tiggelaar SM, Smith JS, Sahasrabuddhe VV, Qiao YL.

Virol J. 2014 Dec 7;11:202. doi: 10.1186/s12985-014-0202-3.

12.

High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.

Reddy D, Njala J, Stocker P, Schooley A, Flores M, Tseng CH, Pfaff C, Jansen P, Mitsuyasu RT, Hoffman RM.

Int J STD AIDS. 2015 May;26(6):379-87. doi: 10.1177/0956462414539149. Epub 2014 Jun 13.

13.

Relationship of immunologic response to antiretroviral therapy with non-AIDS defining cancer incidence.

Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ.

AIDS. 2014 Apr 24;28(7):979-87. doi: 10.1097/QAD.0000000000000167.

14.

Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.

Huchko MJ, Leslie H, Maloba M, Bukusi EA, Cohen CR.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):188-92. doi: 10.1097/QAI.0000000000000130.

15.

The burden of human papillomavirus infections and related diseases in sub-saharan Africa.

De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP.

Vaccine. 2013 Dec 29;31 Suppl 5:F32-46. doi: 10.1016/j.vaccine.2012.07.092. Review.

16.

Variants in interleukin family of cytokines genes influence clearance of high risk HPV in HIV-1 coinfected African-American adolescents.

Sudenga SL, Wiener HW, Shendre A, Wilson CM, Tang J, Shrestha S.

Hum Immunol. 2013 Dec;74(12):1696-700. doi: 10.1016/j.humimm.2013.08.010. Epub 2013 Aug 21.

17.

Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.

Huchko MJ, Leslie H, Sneden J, Maloba M, Abdulrahim N, Bukusi EA, Cohen CR.

Int J Cancer. 2014 Feb 1;134(3):740-5. doi: 10.1002/ijc.28401. Epub 2013 Sep 13.

18.

Comparing Papanicolau smear, visual inspection with acetic acid and human papillomavirus cervical cancer screening methods among HIV-positive women by immune status and antiretroviral therapy.

Chung MH, McKenzie KP, De Vuyst H, Richardson BA, Rana F, Pamnani R, Njoroge JW, Nyongesa-Malava E, Sakr SR, John-Stewart GC, Mugo NR.

AIDS. 2013 Nov 28;27(18):2909-19. doi: 10.1097/01.aids.0000432472.92120.1b.

19.

Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.

Rositch AF, Gravitt PE, Tobian AA, Newell K, Quinn TC, Serwadda D, Ssebbowa P, Kiggundu V, Gray RH, Reynolds SJ.

PLoS One. 2013;8(1):e55383. doi: 10.1371/journal.pone.0055383. Epub 2013 Jan 29.

20.

Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya.

De Vuyst H, Mugo NR, Chung MH, McKenzie KP, Nyongesa-Malava E, Tenet V, Njoroge JW, Sakr SR, Meijer CM, Snijders PJ, Rana FS, Franceschi S.

Br J Cancer. 2012 Oct 23;107(9):1624-30. doi: 10.1038/bjc.2012.441. Epub 2012 Oct 2.

Supplemental Content

Support Center